Spectral AI, Inc. Class A Common Stock

Day range

$1.44 – $1.50

Open

$1.44

Prev close

$1.44

Volume

31.74K

Market cap

$46.35M

Shares out

32.18M

P/E

—

P/S

3.01

P/B

-3.84

P/FCF

—

ROE

83.7%

ROA

-51.9%

Debt/Equity

-1.24

Div yield

0.00%

As of Oct 23, 2026

• Investor presentationSep 15, 2026

  On September 14, 2026, the Company posted an investor presentation to its website at www.spectral-ai.com (the "Investor Presentation"). A copy of the Investor Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

• Executive officer appointmentJul 8, 2026

  the Board of Directors (the "Board") of the Spectral AI, Inc. (the "Company") have appointed Darcy Bajko to the position of Chief Commercial Officer beginning on July 31, 2026 (the "Effective Date"). Mrs. Bajko joins Spectral AI from MediView XR, where she spent the past five years in a series of commercial leadership roles, most recently serving as Vice President of Commercialization and Customer Success since 2024.

• Regulatory decisionMay 26, 2026

  the U.S. Food and Drug Administration granted De Novo Classification for its DeepView® System. With this classification, the Company is authorized to commence commercial distribution activities in the United States.

• Executive compensation changeApr 22, 2026

  Mr. Capone will receive annual base compensation of $500,000. He will be eligible for an annual target bonus of up to 100% of his annual base compensation, but no less than $250,000, payable upon the achievement of certain milestones and performance goals, as specified by the Board. He will be granted restricted stock units ("RSUs") under and subject to the terms of the Company's 2023 Long Term Incentive Plan to acquire 200,000 shares of common stock. The RSUs will vest as follows: (i) 50% of the outstanding RSUs vested on April 1, 2026, and (ii) 50% of the outstanding RSUs will vest on April 1, 2027. Upon a change of control of the Company, the RSUs will become fully vested immediately prior to the change of control.

• Cfo appointmentApr 8, 2026

  The Board of Directors of the Spectral AI, Inc. have appointed David McGuire to the position of Chief Financial Officer beginning on May 4, 2026. Mr. McGuire has over 20 years of experience in finance and accounting, including significant experience in financial reporting, investor relations, financial planning and analysis, capital markets activities, finance transformation, and tax matters.

Days to cover

18.1

Short interest

2.35M

Avg volume

129.68K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• DeepView™ System Featured at 2025 US Burn Conferences
  positiveGlobeNewswire Inc.· Nov 19, 2025
• Spectral AI (MDAI) Q3 2025 Earnings Transcript
  neutralThe Motley Fool· Nov 11, 2025
• Spectral AI Announces 2025 Third Quarter Financial Results
  neutralGlobeNewswire Inc.· Nov 11, 2025
• Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call
  neutralGlobeNewswire Inc.· Oct 28, 2025
• Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025
  positiveGlobeNewswire Inc.· Sep 19, 2025